1 posted on
04/27/2019 12:04:45 PM PDT by
Olog-hai
To: Olog-hai
Over here, FDA 20 year trial before approval. 🌞🏄🏻🏖
2 posted on
04/27/2019 12:10:52 PM PDT by
rktman
( #My2ndAmend! ----- Enlisted in the Navy in '67 to protect folks rights to strip my rights. WTH?)
To: Olog-hai
6 posted on
04/27/2019 3:22:14 PM PDT by
dadfly
To: Olog-hai
"The tumor-reducing drug is aimed at patients with the second most common form of skin cancer — cutaneous squamous cell carcinoma (CSCC) — whose cancer is advanced, and who are not candidates for surgery or radiation therapy." I can't believe this just fell in my lap. I have stage four squamous cell carcinoma.
7 posted on
04/27/2019 3:58:48 PM PDT by
Windflier
(Pitchforks and torches ripen on the vine. Left too long, they become black rifles.)
To: Olog-hai
We’re already using Libtayo where I work. It isn’t cheap.
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson